Skip to main content

C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering

$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial in Combination with Dexamethasone and Phase 1b Trial in Combination with Elranatamab Potential to Earn up to an Additional $225 Million in Proceeds WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced the pricing of an underwritten offering to a select group of institutional investors consisting of 21,895,000 shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase an aggregate of up to 28,713,500 shares of its common stock. Each share of common stock and each pre-funded warrant...

Continue reading

West Virginia and Diversified Energy Launch First-Of-Its-Kind Well Plugging Fund

West Virginia and Diversified Energy Launch First-Of-Its-Kind Well Plugging Fund The “Mountain State Plugging Fund” is a groundbreaking partnership that provides financial assurance for oil and gas well retirement at no cost to taxpayers CHARLESTON, West Virginia and BIRMINGHAM, Alabama, Oct. 16, 2025 (GLOBE NEWSWIRE) — Governor Patrick Morrisey, in partnership with Diversified Energy (NYSE & LSE: DEC), today announced a groundbreaking agreement to establish the nation’s first financial assurance fund dedicated to retiring oil and gas wells. This public-private collaboration solidifies the Company’s commitment to fiscal responsibility and financial means for future well retirement and provides the public with assurances that West Virginia companies will be good stewards of the environment. Known as the Mountain State Plugging...

Continue reading

Genco Shipping & Trading Limited Announces Delivery of High Specification Capesize Vessel

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today announced that it has taken delivery of the Genco Courageous, a 2020-built 182,000 dwt scrubber-fitted Capesize vessel. John C. Wobensmith, Chief Executive Officer, commented, “We are pleased to take delivery of this high specification, fuel efficient Capesize vessel, which expands the Company’s presence in a key sector and marks approximately $200 million invested in modern Capesize vessels since October 2023. Importantly, we continue to take steps to modernize our asset base and improve our earnings capacity at a time of favorable long-term industry fundamentals. Moving forward, we remain committed to...

Continue reading

Bowman to Attend November Investor Conferences

RESTON, Va., Oct. 16, 2025 (GLOBE NEWSWIRE) — Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, announced it will participate in the following November investor conferences:Baird Global Industrial Conference, held November 11-13 in Chicago Craig-Hallum Alpha Select Conference, held November 18 in New York CityAbout Bowman Consulting Group Ltd.Headquartered in Reston, Virginia, Bowman is a national engineering services firm delivering infrastructure, technology and project management solutions to customers who own, develop and maintain the built environment. With 2,500 employees and 100 locations throughout the United States, Bowman provides extensive planning, engineering, geospatial, construction management, commissioning, environmental consulting, land procurement and...

Continue reading

Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call

ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 6, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13755427. The replay will be available until November 13, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations...

Continue reading

Endeavour Silver Announces Commercial Production at Terronera

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) is pleased to announce it has achieved commercial production at the Terronera mine (“Terronera”) located in Jalisco state, Mexico, effective October 1, 2025. The declaration of commercial production at Terronera comes after a successful commissioning phase during which both mining and processing operations were ramped up to consistently exceed an average of 90% of the designed nameplate capacity of 2,000 tonnes per day, while also achieving at least 90% of the projected metal recoveries. Terronera has demonstrated remarkable progress, operating for 100 days since July 1, 2025, with eight days of downtime, and has sustained strong metal recoveries since mid-August. This...

Continue reading

ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting

Presentation at AAO 2025 part of ongoing NEW DAY data dissemination at medical meetings PRINCETON, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that results from the NEW DAY clinical trial of ILUVIEN® (fluocinolone acetonide intravitreal implant), 0.19 mg (ILUVIEN) for use in appropriate patients with diabetic macular edema (DME) will be presented in a late-breaking oral presentation during Retina Subspecialty Day 2025, being held October 17-18, 2025 at the American Academy of Ophthalmology (AAO) 2025 Meeting. The results from the NEW DAY trial have been previously reported. “We are excited that these results will be presented in a late-breaking oral presentation at AAO 2025, which is the largest meeting of ophthalmologists in the U.S.,” stated Nikhil Lalwani,...

Continue reading

Ring Energy Announces Timing of Third Quarter 2025 Earnings Release and Conference Call

THE WOODLANDS, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) — Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced the timing of its third quarter 2025 earnings release and conference call. Ring plans to issue its third quarter 2025 earnings release after the close of trading on Thursday, November 6, 2025. The Company has scheduled a conference call on Friday, November 7, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss its third quarter operational and financial results. To participate, interested parties should dial 833-953-2433 at least five minutes before the call is to begin. Please reference the “Ring Energy Earnings Conference Call”. International callers may participate by dialing 412-317-5762. The call will also be webcast and available on Ring’s website at www.ringenergy.com under “Investors” on the...

Continue reading

DT Midstream to Announce Third Quarter 2025 Financial Results, Schedules Earnings Call

DETROIT, Oct. 16, 2025 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) plans to announce third quarter 2025 financial results before the market opens on Thursday, October 30, 2025. DT Midstream has scheduled a conference call to discuss results for 9:00 a.m. ET (8:00 a.m. CT) the same day. Investors, the news media and the public may listen to a live internet broadcast of the call at this link. The participant toll-free telephone dial-in number in the U.S. and Canada is 888.596.4144, and the toll number is 646.968.2525; the passcode is 9881735. International access numbers are available here. The webcast will be archived on the DT Midstream website at investor.dtmidstream.com. About DT Midstream DT Midstream (NYSE: DTM) is an owner, operator and developer of natural gas interstate and intrastate pipelines, storage and gathering...

Continue reading

Chery TIGGO7 CSH and TIGGO8 CSH Earn Five-Star Safety Rating from Euro NCAP

WUHU, China, Oct. 16, 2025 (GLOBE NEWSWIRE) — On October 15, Chery’s TIGGO7 CSH and TIGGO8 CSH both received the highest five-star safety rating from the European New Car Assessment Programmed (Euro NCAP) in its latest round of assessment. This accomplishment underscores Chery’s longstanding expertise in both active and passive safety technologies and further strengthens its reputation for safety in the global automotive market.(Euro NCAP official website screenshot) As one of the world’s most authoritative vehicle safety assessment organizations, Euro NCAP evaluates vehicles across four key areas: Adult Occupant Protection, Child Occupant Protection, Vulnerable Road User Protection, and Safety Assist. In the latest testing round, both TIGGO7 CSH and TIGGO8 CSH delivered outstanding performances — scoring 82%...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.